What is Gyre Therapeutics, Inc.'s net margin?

Gyre Therapeutics, Inc. (GYRE) reported net margin of 6.3% in Q3 2025.

How has Gyre Therapeutics, Inc.'s net margin changed year-over-year?

Gyre Therapeutics, Inc.'s net margin increased by 108.6% year-over-year, from -73.3% to 6.3%.

What is the long-term trend for Gyre Therapeutics, Inc.'s net margin?

Over 3 years (2020 to 2024), Gyre Therapeutics, Inc.'s net margin has grown at a -65.0% compound annual growth rate (CAGR), from -268.5% to 11.5%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Gyre Therapeutics, Inc. GYRE Net margin

Net margin at other companies

Eli LillyLLY

35%+12.3pp

Madrigal Pharmaceuticals, Inc.MDGL

-27.3%-12.0pp

Theravance BiopharmaTBPH

104.3%+71.4pp

Rigel PharmaceuticalsRIGL

121.5%+103pp

Zevra Therapeutics, Inc.ZVRA

101.6%+60.1pp

LQD

Liquidia CorporationLQDA

-176.2%-76.4pp

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Calculated from Gyre Therapeutics, Inc.’s reported figures.

net income/total revenue=6.3%

Based on trailing twelve months.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s net margin?: Gyre Therapeutics, Inc. (GYRE) reported net margin of 6.3% in Q3 2025.
How has Gyre Therapeutics, Inc.'s net margin changed year-over-year?: Gyre Therapeutics, Inc.'s net margin increased by 108.6% year-over-year, from -73.3% to 6.3%.
What is the long-term trend for Gyre Therapeutics, Inc.'s net margin?: Over 3 years (2020 to 2024), Gyre Therapeutics, Inc.'s net margin has grown at a -65.0% compound annual growth rate (CAGR), from -268.5% to 11.5%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.